.jpg)
Hearing aid company Demant's business has been booming in the first half of 2021 – so much so that the group now books an upward adjustment of its full-year guidance.
Demant now banks on organic growth of 26-30 percent against the prior spread of 24-28 percent, also dialing up on its expectations for annual earnings before interest and taxes from DKK 3-3.3bn (USD 470-520m) to DKK 3.15-3.45bn, the company informs in its H1 interim report.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Evaxion Biotech Careers 
Analysis Chemist for Quality Control in Orifarm Manufacturing Viminco 
Analytical Coordinator - Symphogen 
Clinical Research Specialist, Post Market Clinical Development - Ambu 
Scientific Advisor infectious disease - Vaccibody 
Medical Director (diabetes and obesity) - Zealand Pharma 
Global Senior Medical Advisor – Neurology Pipeline Projects, Lundbeck 
Associate Director, PV QA - Y-mAbs Therapeutics 
KLIFO is looking for a talented Medical Writer (DK, SE or DE) 
CMC Senior Project Manager - Genmab 
Employee of the regulatory department with knowledge of food safety and legislation within dietary supplements and medicines 
A tech-savvy Project Manager Oncology (m/f/x) with a passion for communication and cross-functional collaboration - Daiichi-Sankyo 
Project Manager, Adcendo ApS